Literature DB >> 6889817

Prevalene of perimenstrual symptoms.

N F Woods, A Most, G K Dery.   

Abstract

The purpose of this study was to determine the prevalence of perimenstrual symptoms (PMS) in a free-living population of US women and to determine if prevalence estimates varied with parity, contraceptive status, characteristics of the menstrual cycle, and selected demographic variables. We identified all households from a census listing for five southeastern city neighborhoods that offered variation in racial composition and socioeconomic status. We ascertained all households in which there was one nonpregnant woman between the ages of 18 and 35 years per household. Of the 241 eligible women, 179 (74 per cent) participated in the study. Trained interviewers administered the Moos Menstrual Distress Questionnaire (MDQ) and other demographic measures to women between March and July 1979. Symptoms with a prevalence greater than 30 per cent included weight gain, headache, skin disorders, cramps, anxiety, backache, fatigue, painful breasts, irritability, mood swings, depression, or tension. Only 2 to 8 per cent of women found most of these severe or disabling. The exceptions were severe cramps reported by 17 per cent of women and severe premenstrual and menstrual irritability by 12 per cent. Cramps, backaches, fatigue, and tension were most prevalent during the menstruum; weight gain, skin disorders, painful breasts, swelling, irritability, mood swings, and depression were more prevalent in the premenstruum. Parity, oral contraceptive use, age, employment, education, and income were negatively associated with selected PMS. Use of an IUD, having long menstrual cycles, long menstrual flow, or heavy menstrual flow, and being able to predict the next period were positively associated with selected PMS. Race had both positive and negative effects on PMS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889817      PMCID: PMC1650411          DOI: 10.2105/ajph.72.11.1257

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  22 in total

1.  Daily self-reports on activities, life events, moods, and somatic changes during the menstrual cycle.

Authors:  L A Wilcoxon; S L Schrader; C W Sherif
Journal:  Psychosom Med       Date:  1976 Nov-Dec       Impact factor: 4.312

2.  Dysmenorrhea in industrial workers.

Authors:  P Bergsjo; H Jenssen; O D Vellar
Journal:  Acta Obstet Gynecol Scand       Date:  1975       Impact factor: 3.636

3.  The prevalence of common menstrual symptoms.

Authors:  N KESSEL; A COPPEN
Journal:  Lancet       Date:  1963-07-13       Impact factor: 79.321

4.  The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.

Authors:  B M Sherman; J H West; S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

5.  Variations in menstrual cycle symptom reporting.

Authors:  P Sheldrake; M Cormack
Journal:  J Psychosom Res       Date:  1976       Impact factor: 3.006

6.  Contraceptive pills and day-by-day feelings of well-being.

Authors:  N M Morris; J R Udry
Journal:  Am J Obstet Gynecol       Date:  1972-07-15       Impact factor: 8.661

7.  Cross cultural study of premenstrual symptoms.

Authors:  O Janiger; R Riffenburgh; R Kersh
Journal:  Psychosomatics       Date:  1972 Jul-Aug       Impact factor: 2.386

8.  Effects of oral contraceptives on affective fluctuations associated with the menstrual cycle.

Authors:  K E Paige
Journal:  Psychosom Med       Date:  1971 Nov-Dec       Impact factor: 4.312

9.  The development of a menstrual distress questionnaire.

Authors:  R H Moos
Journal:  Psychosom Med       Date:  1968 Nov-Dec       Impact factor: 4.312

10.  Premenstrual symptoms and depression in a university population.

Authors:  M A Schuckit; V Daly; G Herrman; S Hineman
Journal:  Dis Nerv Syst       Date:  1975-09
View more
  24 in total

1.  Developmental associations between adolescent change in depressive symptoms and menstrual-cycle-phase-specific negative affect during early adulthood.

Authors:  Jeff Kiesner; François Poulin
Journal:  J Youth Adolesc       Date:  2011-10-16

2.  Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women.

Authors:  Jin Pyo Hong; Subin Park; Hee-Ryung Wang; Sung Man Chang; Jee Hoon Sohn; Hong Jin Jeon; Hae Woo Lee; Seong-Jin Cho; Byung-Soo Kim; Jae Nam Bae; Maeng Je Cho
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-27       Impact factor: 4.328

Review 3.  Premenstrual syndrome as a criminal defense.

Authors:  J W Lewis
Journal:  Arch Sex Behav       Date:  1990-10

4.  [SIPS--screening instrument for premenstrual symptoms. The German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances].

Authors:  D Bentz; M Steiner; G Meinlschmidt
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

5.  Symptoms-Based Phenotypes Among Women With Dysmenorrhea: A Latent Class Analysis.

Authors:  Chen X Chen; Susan Ofner; Giorgos Bakoyannis; Kristine L Kwekkeboom; Janet S Carpenter
Journal:  West J Nurs Res       Date:  2017-09-15       Impact factor: 1.967

6.  Epidemiology of premenstrual symptoms.

Authors:  C A Boyle; G S Berkowitz; J L Kelsey
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

7.  Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study.

Authors:  P J Goodwin; G DeBoer; R M Clark; P Catton; S Redwood; N Hood; N F Boyd
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

8.  Prevalence of perimenstrual symptoms and response bias.

Authors:  M A Strassburg
Journal:  Am J Public Health       Date:  1983-05       Impact factor: 9.308

9.  Caffeine-containing beverages and premenstrual syndrome in young women.

Authors:  A M Rossignol
Journal:  Am J Public Health       Date:  1985-11       Impact factor: 9.308

Review 10.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.